At Jean Walter Infusion Center, we acknowledge the financial concern of health treatments and are committed to making IV therapy accessible for all
Antidepressant use in IBS is associated with a higher risk of all-cause mortality across subclasses and patient subgroups, whereas antispasmodics are not associated with increased mortality
The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo, establishing a clear evidence base for GLP-1 receptor agonists as the current standard for pharmacological weight management
Our recent blog explores how peptide therapies support metabolic change, which treatments are backed by clinical evidence, and what you should know before considering them as part of a weight loss plan
Bulk purchasing or distribution may constitute a criminal offence, with penalties including fines and imprisonment
The gradual effect is maintained for up to 4 weeks with dapagliflozin [21] and has been explained by the reduction in visceral and subcutaneous fat mass [21,22,23]
:format(webp))
